폐경기 관련 우울증의 평가와 치료 = Diagnosis and Treatment of Menopause-Related Depression

다국어 초록 (Multilingual Abstract)

Recent Korean statistics show that a Korean woman can now expect to live until her mid-80s, which implies living at least one-third of her life after menopause. The menopausal transition is typically marked by intense hormonal fluctuations, accompanied by sleep disturbance, vasomotor symptoms(e.g., hot flashes, night sweats), increased risk for osteoporosis, cardiovascular disease, and developing depression as well as mood disturbances. These symptoms can affect a woman's quality of life negatively. Therefore, a comprehensive understanding of the accurate detection and appropriate treatment of various menopause-related symptoms including depression in the menopausal transitions and postmenopause is mandatory. This review primarily focused on the current knowledge about the treatment of menopause-related depression.

참고문헌 (Reference)

1 Ockene JK, "symptom experience after discontinuing use of estrogen plus progestin" 294 : 183-193, 2005

2 Odmark IS, "Well-being at onset of hormone replacement therapy: comparison between two continuous combined regimens" 7 : 92-102, 2004

3 Joffe H, "Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care" 9 : 392-398, 2002

4 Joffe H, "Treatment of depression and menopause-related symptoms with the serotonin-norepiniphrine reuptake inhibitor duloxetine" 68 : 943-950, 2007

5 Worthington JJ III, "Treatment of antidepressant-induced sexual dysfunction" 39 : 887-896, 2003

6 Bergstrom I, "Training or EPT in perimenopause on balance and flushes" 86 : 467-472, 2007

7 Soares CN, "The role of reproductive hormones in the management of depression during menopause" 20 : 85-100, 2003

8 McKinlay SM, "The normal menopause transition" 14 : 103-115, 1992

9 Irvin JH, "The effects of relaxation response training on menopausal symptoms" 17 : 202-207, 1996

10 Jaszmann L, "The age of menopause in the Netherlands: the statistical analysis of a survey" 14 : 106-117, 1969

11 Hunter M, "The South-East England longitudinal study of the climacteric and postmenopause" 14 : 117-126, 1992

12 Kaufert PA, "The Manitoba Project: a re-examination of the link between menopause and depression" 14 : 143-155, 1992

13 Roberts RE, "The Center for Epidemiologic Studies Depression Scale: its use in a community sample" 14 : 41-46, 1983

14 Mitchell ES, "Symptom experiences of midlife women: observations from the Seattle midlife women’s health study" 25 : 1-10, 1996

15 Schmidt PJ, "Stressful life events, personal loses, and perimenopause-related depression" 7 : 19-26, 2004

16 Walters V, "Stress, anxiety and depression: women’s accounts of their health problems" 36 : 393-402, 1993

17 Baker A, "Sleep disruption and mood changes associated with menopause" 43 : 359-369, 1997

18 Cohen LS, "Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report" 160 : 1519-1522, 2003

19 Kessler RC, "Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence" 29 : 85-96, 1993

20 Writing Group for the Women’s Health Initiative Investigators, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial" 288 : 321-333, 2002

21 Cohen L, "Risk for new onset of depression during the menopausal transition: the Harvard Study of Moods and Cycles" 63 : 385-390, 2006

22 Entsuah AR, "Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo" 62 : 869-877, 2001

23 Amick BC 3rd, "Relationship of job strain and isostrain to healthy status a cohort of women in the United States" 24 : 54-61, 1998

24 Hunter M, "Relationship between psychological symptoms, somatic complaints and menopausal status" 8 : 217-228, 1986

25 Becker D, "Psychological distress around menopause" 42 : 252-257, 2001

26 Burger HG, "Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women" 84 : 4025-4030, 1999

27 Harlow BL, "Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cylces" 56 : 418-424, 1999

28 Richards M, "Premenstrual symptoms and perimenopausal depression" 163 : 133-137, 2006

29 Grady D, "Predictors of difficulty when discontinuing postmenopausal hormone therapy" 102 : 1233-1239, 2003

30 Metcalf MG, "Pituitary ovarian function in normal women during the menopausal transition" 14 : 234-255, 1981

31 Bromberger JT, "Persistent mood symptoms in a multiethnic community cohort of pre-and perimenopausal women" 158 : 347-356, 2003

32 Burt VK, "Perimenopuase and menopause. In: Concise Guide to Women’s Mental Health" American Psychiatric Press 103-115, 1997

33 Woods NF, "Patterns of depressed mood in midlife women: observations from the Seattle Midlife Women’s Health Study" 19 : 111-123, 1996

34 Woods N, "Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women’s Health Study" 20 : 119-129, 1997

35 Soares CN, "Paroxetine versus placebo for women in midlife after hormone therapy discontinuation" 121 : 159-162, 2008

36 Burger H, "Nomenclature and endocrinology of menopause and perimenopause" 7 : S35-S43, 2007

37 Stearns V, "New therapeutic approaches for hot flashes in women" 1 : 11-21, 2003

38 Steiner M, "Mood disorders associated with the menopause. in: Depression in Women" Martin Dunitz 48-59, 1998

39 Dennerstein L, "Mood and the menopausal transition" 187 : 685-691, 1999

40 Schmidt PJ, "Menopause-related affective disorders: a justification for further study" 148 : 844-852, 1991

41 Nelson H, "Management of menopause-related symptoms" 120 : 1-6, 2005

42 Freedman RR, "Lack of sleep disturbance from menopausal hot flashes" 82 : 138-144, 2004

43 Morrison MF, "Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trail" 55 : 406-412, 2004

44 Cheng G, "Isoflavone treatment for acute menopausal symptoms" 14 (14): 468-473, 2007

45 Matthews KA, "Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women" 58 : 345-351, 1990

46 Oldenhave A, "Impact of climacteric on well-being: a survey based on 5213 women 39 to 60 years old" 168 : 772-778, 1993

47 Kronenberg F, "Hot flashes: epidemiology and physiology" 592 : 52-86, 1990

48 Freeman EW, "Hormones and menopausal status as predictors of depression in women in transition to menopause" 61 : 62-70, 2004

49 Dennerstein L, "Hormone therapy and affect" 1 : 247-259, 1979

50 Coope J, "Hormonal and non-hormonal interventions for menopausal symptoms" 23 : 159-168, 1996

51 Kornstein SG, "Gender differences in treatment response to sertraline versus imipramine in chronic depression" 157 : 1445-1452, 2000

52 Freeman EW, "Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women" 10 : 67-76, 2001

53 Soules MR, "Executive summary: stages of reproductive aging workshop" 76 : 267-272, 2001

54 Rubinow DR, "Estrogen-serotonin interactions: implications for affective regulation" 44 : 839-850, 1998

55 Rasgon NL, "Estrogen-replacement therapy for depression" 158 : 1738-, 2001

56 Joffe H, "Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?" 44 : 798-811, 1998

57 Schmidt PJ, "Estrogen replacement in menopausal transition-related depression: a preliminary report" 183 : 414-420, 2000

58 Morgan ML, "Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study" 66 : 774-780, 2005

59 Soares CN, "Escitalopram versus ethinyl estradiol and norethidrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life" 13 : 780-786, 2006

60 Dennerstein L, "Empty nest or revolving door? A prospective study of women’s quality of life in midlife during the phase of children leaving and re-entering the home" 32 : 545-550, 2002

61 Dias RS, "Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study" 13 : 202-211, 2006

62 Soares CN, "Efficacy of estadiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial" 58 : 529-534, 2001

63 Soares CN, "Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms" 64 : 473-479, 2003

64 Dorsey CM, "Effect of zolpidem on sleep in women with perimenopausal and postmnopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study" 26 : 1578-1586, 2004

65 Harlow BL, "Depression and its influence on reproductive endocrine and menstrual cycle markers associated with menopausal transition: the Harvard Study of Moods and Cycles" 60 : 29-36, 2003

66 Woods NF, "Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle midlife women’s health study" 15 : 223-232, 2008

67 Guay MP, "Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after WHI publication" 16 : 17-27, 2007

68 Freeman E, "Associations of hormones and menopausal status with depressed mood in women with no history of depression" 63 : 375-382, 2006

69 Erlik Y, "Association of waking episodes with menopausal hot flushes" 245 : 1741-1744, 1981

70 Harlow BL, "Association of medically treated depression and age at natural menopause" 141 : 1170-1176, 1995

71 Cheung Y, "Association between psychosocial work characteristics and health functioning in American women: prospective study" 320 : 1432-1436, 2000

72 Joffe H, "Assessment and treatment of hot flushes and menopausal mood disturbance" 26 : 563-580, 2003

73 Cassano P, "Antidepressant response and well-being in pre-, peri- and postmnopausal women with major depressive disorder treated with fluoxetine" 74 : 362-365, 2005

74 Woods NF, "Anticipating menopause: observations from the Seattle Midlife Women’s Health Study" 6 : 167-173, 1999

75 Joffe H, "An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy" 10 : 999-1004, 2001

76 Dennerstein L, "A prospective population-based study of menopausal symptoms" 96 : 351-358, 2000

77 Bromberger JT, "A longitudinal study of the effects of pessimism, trait anxiety, and life stress on depressive symptoms in middle-aged women" 11 : 207-213, 1996

78 Schmidt PJ, "A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women" 161 : 2238-2244, 2004

79 Avis NE, "A longitudinal analysis of women’s attitudes toward the menopause: results from the Massachusetts Women’s Health Study" 13 : 65-79, 1991

80 Avis NE, "A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women’s Health Study" 4L214-4L220, 1994